At the Centre for Health Evaluation and Outcome Sciences (CHÉOS), we connect the dots between research and real-world impact by producing high-quality evidence to transform health systems and improve care. Based at St. Paul’s Hospital […]
The National Collaborating Centre for Methods and Tools (NCCMT) supports public health organizations and individuals in Canada to use the best available evidence in their public health practice. We do this by compiling and sharing […]
Over the last 40 years, we — as a society — have seen incredible progress in the way illnesses, such as cancer are treated. We owe these advances to medical research and the millions of […]
When Drs. Banting, Best, Collip and MacLeod discovered insulin in Toronto in the summer of 1921, they saved the lives of millions of people around the world. I doubt they could have really imagined how […]
Emerging technologies in the field of Artificial Intelligence (AI) and machine learning are becoming essential tools in the advancement of research in the healthcare space. From hospital care to clinical research, drug development and insurance, […]
Whether it is exercising, brushing teeth, eating well, applying sunscreen, quitting smoking, or treating fevers and headaches, self-care is what every Canadian does to stay healthy and Canadians do prefer to take care of themselves […]
Older Canadians are now the fastest growing segment of our population, with recent demographic projections pointing to one in five Canadians being 65 or older by 2024.[1] This demographic shift will present challenges and opportunities […]
OTTAWA, September 9, 2019 — Canada’s national stem cell and regenerative medicine research organization, the Stem Cell Network (SCN), announced today the launch of its three-year Strategic Plan, ACCELERATE, along with a refreshed brand identity and redesigned logo. […]
Rare disease innovators simply may not seek Canadian approval for new medicines if unable to obtain timely federal approval of prices that are comparable to other countries OTTAWA, August 9, 2019 – Canadians with rare […]
New regs unfairly and unnecessarily target rare disease drugs and all new medicines – including life-saving cancer and curative gene therapies Proposed national pharmacare – including the Drugs for Rare Diseases Program – will be […]
Copyright © 2024 | Research Canada